Klaus L Leenders Selected Research

Synucleinopathies

1/2021

Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaus L Leenders Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2003
3	Cognitive Dysfunction 01/2021 - 09/2015
3	REM Sleep Behavior Disorder 01/2021 - 10/2017
2	Anosmia 01/2022 - 10/2017
2	Multiple System Atrophy 01/2021 - 04/2013
2	Dementia (Dementias) 01/2021 - 01/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2013
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2020 - 04/2013
2	Parkinsonian Disorders (Parkinsonism) 01/2020 - 02/2016
2	Brain Diseases (Brain Disorder) 10/2010 - 09/2004
2	Neuroinflammatory Diseases 03/2010 - 10/2007
1	Synucleinopathies 01/2021
1	Disease Progression 01/2021
1	Tremor (Tremors) 01/2016
1	Hypokinesia (Bradykinesia) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Huntington Disease (Huntington's Disease) 09/2013
1	Dystonia (Limb Dystonia) 09/2012
1	Psychotic Disorders (Schizoaffective Disorder) 07/2008
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2008
1	Dyskinesias (Dyskinesia) 03/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2004
1	Atherosclerosis 09/2004
1	Glioma (Gliomas) 11/2002
1	Brain Neoplasms (Brain Tumor) 11/2002
1	Neoplasms (Cancer) 11/2002

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2013
5	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2014
3	Levodopa (L Dopa)FDA LinkGeneric 02/2016 - 09/2004
2	fluorodopa F 18IBA 01/2020 - 01/2008
2	Dihydroxyphenylalanine (Dopa)IBA 01/2020 - 01/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2017
2	Deoxyglucose (2 Deoxy D glucose)IBA 04/2013 - 10/2010
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2022
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022
1	SynucleinsIBA 01/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2016
1	4- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinoneIBA 09/2015
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2010
1	LigandsIBA 07/2008
1	sigma Receptors (sigma Receptor)IBA 07/2008
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 10/2007
1	Dopamine Agonists (Dopamine Agonist)IBA 03/2006
1	Pergolide (Permax)FDA Link 03/2006
1	Biological ProductsIBA 09/2004
1	NeurotoxinsIBA 09/2004
1	dibenzo(b,f)oxepin- 10- ylmethyl- methyl- prop- 2- ynyl- amine (TCH346)IBA 11/2003
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2003
1	propargylamineIBA 11/2003
1	Pharmaceutical PreparationsIBA 11/2002
1	Idoxuridine (Stoxil)FDA LinkGeneric 11/2002
1	DNA (Deoxyribonucleic Acid)IBA 11/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 09/2013
1	Transcranial Magnetic Stimulation 09/2012
1	Intravenous Injections 11/2002